# Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer

> **NCT01400620** · PHASE2 · COMPLETED · sponsor: **Izun Pharma Ltd** · enrollment: 110 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** IZN-6N4

## Key facts

- **NCT ID:** NCT01400620
- **Lead sponsor:** Izun Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01400620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01400620, "Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01400620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*